title: [Hypertrophic cardiomyopathy with restrictive pathophysiology: is there a role for cardiopulmonary exercise testing?].
authors.forename: Michele
authors.initials: M
authors.lastname: Correale
authors.forename: Tommaso
authors.initials: T
authors.lastname: Passero
authors.forename: Antonio
authors.initials: A
authors.lastname: Totaro
authors.forename: Matteo
authors.initials: M
authors.lastname: Di Biase
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy* / Q000503:physiopathology*; D002313:Cardiomyopathy, Restrictive / Q000188:drug therapy* / Q000503:physiopathology*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*
chemical_list: D000083:Acetanilides; D002317:Cardiovascular Agents; D004791:Enzyme Inhibitors; D010879:Piperazines